Clinical Trial Update: Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

View source ↗

Summary

This clinical trial update discusses the use of Iscador Qu as supportive treatment in pancreatic cancer (UICC stages II-IV), sponsored by IFAG AG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Iscador Qu (Viscum album extract)

Snippet

Sponsor: IFAG AG | Conditions: Pancreas Cancer | Status: UNKNOWN